vs
Side-by-side financial comparison of Apyx Medical Corp (APYX) and TELEFLEX INC (TFX). Click either name above to swap in a different company.
TELEFLEX INC runs the higher net margin — 177.8% vs -6.8%, a 184.5% gap on every dollar of revenue. On growth, Apyx Medical Corp posted the faster year-over-year revenue change (34.7% vs -150.5%). Apyx Medical Corp produced more free cash flow last quarter ($-2.8M vs $-92.9M). Over the past eight quarters, TELEFLEX INC's revenue compounded faster (NaN% CAGR vs NaN%).
Bovie Medical Corporation was an American medical device manufacturer of medical devices, electrosurgical products and energy technologies. It was based in Clearwater, Florida with a manufacturing facility in Bulgaria.
Teleflex Incorporated, headquartered in Wayne, Pennsylvania, is an American provider of specialty medical devices for a range of procedures in critical care and surgery. Teleflex has annual revenues of $2.4 billion, operations in 40 countries, and more than 15,000 employees. By 2011, the company had substantially realigned to focus on its current business as a medical-device manufacturer, having undergone several years of active acquisitions and divestitures. Teleflex has been associated with...
APYX vs TFX — Head-to-Head
Income Statement — Q4 2025 vs Q4 2025
| Metric | | |
|---|---|---|
| Revenue | $19.2M | $-401.9M |
| Net Profit | $-1.3M | $-714.3M |
| Gross Margin | 62.6% | — |
| Operating Margin | 0.1% | — |
| Net Margin | -6.8% | 177.8% |
| Revenue YoY | 34.7% | -150.5% |
| Net Profit YoY | 71.9% | -422.7% |
| EPS (diluted) | — | $-15.85 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $19.2M | $-401.9M | ||
| Q3 25 | $12.9M | $913.0M | ||
| Q2 25 | $11.4M | $780.9M | ||
| Q1 25 | $9.4M | $700.7M | ||
| Q4 24 | $14.2M | $795.4M | ||
| Q3 24 | $11.5M | $764.4M | ||
| Q2 24 | $12.1M | $749.7M | ||
| Q1 24 | $10.2M | $737.8M |
| Q4 25 | $-1.3M | $-714.3M | ||
| Q3 25 | $-2.0M | $-408.9M | ||
| Q2 25 | $-3.8M | $122.6M | ||
| Q1 25 | $-4.2M | $95.0M | ||
| Q4 24 | $-4.6M | $-136.7M | ||
| Q3 24 | $-4.7M | $111.0M | ||
| Q2 24 | $-6.6M | $80.0M | ||
| Q1 24 | $-7.6M | $15.3M |
| Q4 25 | 62.6% | — | ||
| Q3 25 | 64.4% | 49.5% | ||
| Q2 25 | 62.3% | 55.2% | ||
| Q1 25 | 60.1% | 55.6% | ||
| Q4 24 | 63.0% | 55.3% | ||
| Q3 24 | 60.5% | 56.3% | ||
| Q2 24 | 61.7% | 55.6% | ||
| Q1 24 | 58.1% | 56.4% |
| Q4 25 | 0.1% | — | ||
| Q3 25 | -6.5% | -44.8% | ||
| Q2 25 | -22.6% | 19.9% | ||
| Q1 25 | -32.4% | 17.9% | ||
| Q4 24 | -21.4% | -13.9% | ||
| Q3 24 | -31.6% | 19.5% | ||
| Q2 24 | -45.7% | 15.6% | ||
| Q1 24 | -64.6% | -0.6% |
| Q4 25 | -6.8% | 177.8% | ||
| Q3 25 | -15.4% | -44.8% | ||
| Q2 25 | -33.2% | 15.7% | ||
| Q1 25 | -44.0% | 13.6% | ||
| Q4 24 | -32.5% | -17.2% | ||
| Q3 24 | -40.9% | 14.5% | ||
| Q2 24 | -54.0% | 10.7% | ||
| Q1 24 | -74.0% | 2.1% |
| Q4 25 | — | $-15.85 | ||
| Q3 25 | — | $-9.24 | ||
| Q2 25 | — | $2.77 | ||
| Q1 25 | — | $2.07 | ||
| Q4 24 | — | $-2.89 | ||
| Q3 24 | — | $2.36 | ||
| Q2 24 | $-0.19 | $1.69 | ||
| Q1 24 | $-0.22 | $0.32 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $31.7M | $378.6M |
| Total DebtLower is stronger | $37.5M | $2.6B |
| Stockholders' EquityBook value | $14.5M | $3.1B |
| Total Assets | $66.8M | $6.9B |
| Debt / EquityLower = less leverage | 2.58× | 0.85× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $31.7M | $378.6M | ||
| Q3 25 | $25.1M | $354.0M | ||
| Q2 25 | $29.3M | $253.7M | ||
| Q1 25 | $31.0M | $284.1M | ||
| Q4 24 | $31.7M | $290.2M | ||
| Q3 24 | $28.0M | $243.2M | ||
| Q2 24 | $32.7M | $238.6M | ||
| Q1 24 | $37.3M | $237.4M |
| Q4 25 | $37.5M | $2.6B | ||
| Q3 25 | $37.5M | $2.7B | ||
| Q2 25 | $37.5M | $1.9B | ||
| Q1 25 | $37.5M | $1.9B | ||
| Q4 24 | $37.5M | $1.7B | ||
| Q3 24 | $37.5M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $14.5M | $3.1B | ||
| Q3 25 | $5.8M | $3.8B | ||
| Q2 25 | $7.3M | $4.2B | ||
| Q1 25 | $10.5M | $4.1B | ||
| Q4 24 | $14.2M | $4.3B | ||
| Q3 24 | $11.0M | $4.5B | ||
| Q2 24 | $14.7M | $4.6B | ||
| Q1 24 | $20.3M | $4.5B |
| Q4 25 | $66.8M | $6.9B | ||
| Q3 25 | $57.4M | $7.9B | ||
| Q2 25 | $58.2M | $7.4B | ||
| Q1 25 | $60.2M | $7.2B | ||
| Q4 24 | $64.8M | $7.1B | ||
| Q3 24 | $60.7M | $7.5B | ||
| Q2 24 | $65.4M | $7.4B | ||
| Q1 24 | $70.7M | $7.5B |
| Q4 25 | 2.58× | 0.85× | ||
| Q3 25 | 6.41× | 0.70× | ||
| Q2 25 | 5.17× | 0.45× | ||
| Q1 25 | 3.57× | 0.47× | ||
| Q4 24 | 2.64× | 0.39× | ||
| Q3 24 | 3.40× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.5M | $-92.3M |
| Free Cash FlowOCF − Capex | $-2.8M | $-92.9M |
| FCF MarginFCF / Revenue | -14.6% | 23.1% |
| Capex IntensityCapex / Revenue | 1.4% | -0.2% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-9.1M | $1.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-2.5M | $-92.3M | ||
| Q3 25 | $-3.5M | $107.8M | ||
| Q2 25 | $-1.2M | $7.8M | ||
| Q1 25 | $-702.0K | $73.3M | ||
| Q4 24 | $-2.9M | $202.6M | ||
| Q3 24 | $-4.4M | $231.1M | ||
| Q2 24 | $-4.3M | $91.7M | ||
| Q1 24 | $-6.3M | $112.8M |
| Q4 25 | $-2.8M | $-92.9M | ||
| Q3 25 | $-4.1M | $77.8M | ||
| Q2 25 | $-1.5M | $-26.8M | ||
| Q1 25 | $-757.0K | $43.3M | ||
| Q4 24 | $-3.2M | $170.6M | ||
| Q3 24 | $-4.6M | $209.9M | ||
| Q2 24 | $-4.6M | $56.9M | ||
| Q1 24 | $-6.4M | $74.4M |
| Q4 25 | -14.6% | 23.1% | ||
| Q3 25 | -31.5% | 8.5% | ||
| Q2 25 | -13.2% | -3.4% | ||
| Q1 25 | -8.0% | 6.2% | ||
| Q4 24 | -22.4% | 21.4% | ||
| Q3 24 | -40.0% | 27.5% | ||
| Q2 24 | -38.0% | 7.6% | ||
| Q1 24 | -62.2% | 10.1% |
| Q4 25 | 1.4% | -0.2% | ||
| Q3 25 | 4.0% | 3.3% | ||
| Q2 25 | 2.3% | 4.4% | ||
| Q1 25 | 0.6% | 4.3% | ||
| Q4 24 | 1.7% | 4.0% | ||
| Q3 24 | 1.3% | 2.8% | ||
| Q2 24 | 2.4% | 4.6% | ||
| Q1 24 | 0.3% | 5.2% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 0.06× | ||
| Q1 25 | — | 0.77× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 2.08× | ||
| Q2 24 | — | 1.15× | ||
| Q1 24 | — | 7.38× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
